Impact (REF3a/b)

Impact template (REF3a)

Download template (198K)

All impact case studies

Download all case studies (2.4MB)

Individual case studies

Accelerating structural biology with Phaser crystallographic software-Read (141K)

Caesarean section and the risk of perinatal death- Gordon Smith (95K)

Coleman (94K)

Defining first line therapy for high risk essential thrombocythemia-Green (103K)

Development of Campath antibody as a therapeutic-Clark & Waldmann (115K)

Development of risk prediction algorithms for familial breast and ovarian cancer and their use for genetic counselling purposes-Ponder (214K)

Establishing an evidence-based therapeutic approach to ANCA-associated vasculitis-Jayne (105K)

Evidence based imaging – Impact of Body CT and MRI in clinical practice-Dixon (150K)

Genetic diagnosis and therapeutic intervention in patients with severe early onset obesity-o'Rahilly (118K)

Genetic risk assessment for age-related macular degeneration-Yates (207K)

Improved matching of therapeutic platelet concentrates for cancer patients and neonates- Ouewhand (104K)

Increasing access to kidney transplantation-Bradley (105K)

Meeting the diagnostic needs in resource-limited settings (354K)

Molecular markers for diagnosis of myeloproliferative neoplasms-Green (113K)

PREDICT: A prognostication and treatment benefit tool for early breast cancer - Caldas (111K)

Safer antibiotic therapy in cystic fibrosis patients-Floto (53K)

The AB/CD of treating hypertension-Brown (125K)

The ProtecT Trial and Associated Translational Research – Management of Localised Prostate Cancer -Neal (153K)

Therapeutic Developments for Sphingolipidoses-Cox (117K)

Translating Genetic Insights into Improved Clinical Diagnosis and Therapy of Severe Insulin Resistance - O'Rahilly (105K)